Loading...
XTAI3705
Market cap440mUSD
Dec 23, Last price  
54.00TWD
1D
0.19%
1Q
-11.91%
Jan 2017
18.29%
IPO
30.75%
Name

YungShin Global Holding Corp

Chart & Performance

D1W1MN
XTAI:3705 chart
P/E
17.39
P/S
2.05
EPS
3.11
Div Yield, %
4.52%
Shrs. gr., 5y
—
Rev. gr., 5y
-1.33%
Revenues
7.03b
-3.88%
2,809,298,0002,962,109,000940,621,0004,079,435,0004,143,011,0004,501,605,0004,702,806,0005,061,661,0005,826,555,0006,034,169,0006,190,862,0006,622,635,0007,513,686,0008,191,531,0008,084,664,0007,805,055,0007,311,769,0007,027,937,000
Net income
827m
-1.40%
722,221,000470,666,000119,604,000524,219,000635,063,000554,130,000444,535,000618,969,000720,058,000893,254,000657,993,000514,056,000701,982,000748,601,000791,720,000736,622,000839,035,000827,304,000
CFO
1.18b
+22.04%
963,533,000590,064,000128,708,000911,516,000685,209,000356,215,000798,993,0001,193,894,0001,193,596,000556,843,000645,633,000524,555,000953,914,000940,649,0001,227,317,000968,358,000967,245,0001,180,415,000
Dividend
Jun 24, 20242.3 TWD/sh
Earnings
May 29, 2025

Profile

YungShin Global Holding Corporation, through its subsidiaries, engages in the investment, manufacture, and sale of medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics in Taiwan, Mainland China, Japan, and the United States. The company engages in the extraction, manufacture, and sale of wood products; manufacture and sale of over-the-counter drugs, preparations, and chemical intermediates; and pharmaceutical research, transfer, authorization, and outsourcing of services, as well as import and export trading. In addition, it is involved in the trading, wholesale, and retail of health products, cosmetics, medicines, human testing reagents, and the aforesaid related raw materials; semi-finished products; and production equipment. The company was founded in 1952 and is based in Taichung, Taiwan.
URL
http://www.yungshingroup.com/
IPO date
Jan 03, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
7,027,937
-3.88%
7,311,769
-6.32%
7,805,055
-3.46%
Cost of revenue
6,097,734
6,553,889
6,844,423
Unusual Expense (Income)
NOPBT
930,203
757,880
960,632
NOPBT Margin
13.24%
10.37%
12.31%
Operating Taxes
266,314
211,689
242,253
Tax Rate
28.63%
27.93%
25.22%
NOPAT
663,889
546,191
718,379
Net income
827,304
-1.40%
839,035
13.90%
736,622
-6.96%
Dividends
(649,933)
(463,704)
(539,695)
Dividend yield
5.25%
3.78%
4.72%
Proceeds from repurchase of equity
(57,922)
BB yield
0.47%
Debt
Debt current
989,021
1,682,838
2,019,843
Long-term debt
267,357
175,841
737,016
Deferred revenue
359,482
350,933
350,933
Other long-term liabilities
168,131
275,765
174,588
Net debt
(1,748,661)
(1,224,293)
570,826
Cash flow
Cash from operating activities
1,180,415
967,245
968,358
CAPEX
(124,996)
(170,732)
(180,806)
Cash from investing activities
(409,376)
423,029
40,577
Cash from financing activities
(1,195,022)
(702,179)
(1,228,391)
FCF
847,863
1,258,673
547,690
Balance
Cash
1,808,054
2,022,030
1,251,691
Long term investments
1,196,985
1,060,942
934,342
Excess cash
2,653,642
2,717,384
1,795,780
Stockholders' equity
5,576,928
5,364,216
4,636,629
Invested Capital
7,028,359
7,299,214
8,125,829
ROIC
9.27%
7.08%
8.85%
ROCE
9.23%
7.31%
9.37%
EV
Common stock shares outstanding
266,438
266,437
266,433
Price
46.50
1.09%
46.00
7.10%
42.95
-3.91%
Market cap
12,389,367
1.09%
12,256,102
7.10%
11,443,297
-3.92%
EV
11,212,995
11,575,068
12,264,254
EBITDA
1,224,735
1,133,741
1,367,463
EV/EBITDA
9.16
10.21
8.97
Interest
35,277
32,862
30,009
Interest/NOPBT
3.79%
4.34%
3.12%